Summary & Overview
CPT 4144F: Advice to Start Alternative Long-Term Control Medication for Persistent Asthma
CPT code 4144F documents when a clinician advises a patient with persistent asthma to take an alternative long-term control medication. Nationally, this code captures a specific clinical counseling action used in asthma management and can influence chronic care quality measurement and medication adherence tracking. Payers commonly recognizing or tracking this service include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will learn what the code represents in clinical workflows, where the service typically occurs (outpatient and ambulatory settings), and how it fits into broader asthma management and quality measurement. The publication reviews benchmarks and payer recognition where available, clarifies the clinical context for use (switching or initiating controller therapy for persistent asthma), and highlights implications for documentation and coding accuracy. Data not available in the input for associated modifiers, taxonomies, ICD-10 diagnoses, related codes, and detailed payer policy differences; those elements are noted as unavailable and should be sourced from payer policy manuals or clinical documentation resources.
Billing Code Overview
CPT code 4144F indicates that the provider advises the intake of an alternative long term control medication to a patient with a diagnosis of persistent asthma. This denotes clinician counseling focused on changing or initiating a different maintenance therapy for persistent asthma management.
-
Service type: Medication management / therapeutic counseling for chronic respiratory disease
-
Typical site of service: Outpatient clinic or ambulatory care setting, including primary care offices and specialty pulmonary/allergy clinics
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult or pediatric patient with a documented diagnosis of persistent asthma who presents for ambulatory follow-up to review symptoms and controller therapy. The patient reports ongoing daytime symptoms, nighttime awakenings, or rescue inhaler overuse despite current therapy. The clinician (often a primary care physician, pediatrician, family medicine physician, or allergy/immunology specialist) performs a focused asthma control assessment, reviews current inhaled corticosteroid or other long‑term control agents, discusses adherence and inhaler technique, and advises an alternative long‑term controller medication when indicated. Counseling and shared decision‑making are documented, including the reason for change (insufficient control, adverse effects, adherence issues, comorbidities, or formulation preferences). Typical workflow includes review of prior medications, assessment of severity and control (symptom frequency, rescue use, exacerbation history), consideration of step‑up or step‑change therapy, prescription or prior authorization initiation for the alternative long‑term control agent, and plan for follow‑up monitoring. Typical site of service is an outpatient clinic or office visit; telehealth visits are also common for medication counseling and management.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of a procedure | Use when a distinct E/M visit is provided the same day as a procedure or service in addition to counseling about controller therapy. |